Medicare to cover new Alzheimer's drug after full approval

 The Centers for Medicare & Medicaid Services said on Thursday that the U.S. Medicare health plan would cover new Alzheimer's drugs such as Eisai Co Ltd and Biogen Inc's Leqembi if they gain full U.S. approval.

Currently, Medicare - the government health plan for Americans 65 and over - will only pay for Alzheimer's disease drugs approved under the FDA's rigorous accelerated review if patients are enrolled in a clinical trial. 

https://finance.yahoo.com/news/medicare-cover-alzheimers-drug-full-130704773.html